ACTINIUM PHARMACEUTICALS, INC. Equity, Fair Value Adjustment
ACTINIUM PHARMACEUTICALS, INC. (ATNM) reported Equity, Fair Value Adjustment of $2.10 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-16.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures
us-gaap:EquityFairValueAdjustment · last filed 2015-03-16
- ACTINIUM PHARMACEUTICALS, INC. equity, fair value adjustment for fiscal 2014 was $2.10M.
| Period end | Equity, Fair Value Adjustment 1 month | Equity, Fair Value Adjustment 6 month | Equity, Fair Value Adjustment 12 month |
|---|---|---|---|
| 2014-12-31 | $2.10M 10-K · filed 2015-03-16 | ||
| 2014-06-30 | $1.20M 10-Q · filed 2014-10-31 | ||
| 2014-02-28 | $600.00K 10-Q · filed 2014-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |